Concepedia

Barbara Merelli

BM

Statistics

Publications

26

Citations

1.3K

H-Index

19

Active since

2010

Affiliations

Ospedale Papa Giovanni XXIII(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Turin

Istituto Oncologico Veneto

European Institute of Oncology

Barbara Merelli is an author at Ospedale Papa Giovanni XXIII specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2010–2024

26

Publications

26

PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics

Daniela Massi, Davide Brusa, Barbara Merelli et al. · Annals of Oncology · 2014 · 145 citations · Full text

, , +8

Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma

Ailin Lepletier, Jason Madore, Jake S. O’Donnell et al. · Clinical Cancer Research · 2020 · 107 citations · Full text

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

Georgina V. Long, Axel Hauschild, Mario Santinami et al. · New England Journal of Medicine · 2024 · 100 citations

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

Vanna Chiarion‐Sileni, Jacopo Pigozzo, Paolo A. Ascierto et al. · Journal of Experimental & Clinical Cancer Research · 2014 · 99 citations · Full text

The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600

Daniela Massi, Davide Brusa, Barbara Merelli et al. · Annals of Oncology · 2015 · 98 citations · Full text

, , +10

1–5 of 26